Clinical Trials Directory

Trials / Completed

CompletedNCT03270150

Effect of the BTL-899 Therapy for Non-invasive Lipolysis and Circumference Reduction of Abdomen

Evaluation of Safety and Efficacy of the BTL-899 Device for Non-invasive Lipolysis and Circumference Reduction of Abdomen

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
BTL Industries Ltd. · Industry
Sex
All
Age
22 Years
Healthy volunteers
Accepted

Summary

The study is a prospective open-label single-arm study that includes three treatment procedures and four follow-up visits.

Detailed description

This study will evaluate the clinical efficacy and safety of the BTL-899 device for non-invasive lipolysis and circumference reduction of abdomen. The study is a prospective open-label single-arm study. The subjects will be enrolled and assigned into a single study group. Subjects will complete three (3) treatment visits and will be invited to four (4) follow-up visits 1, 2, 3 and 6-months after the final treatment. 6-months follow-up visit is the optional one.

Conditions

Interventions

TypeNameDescription
DEVICEBTL-899BTL-899

Timeline

Start date
2017-09-01
Primary completion
2018-09-19
Completion
2018-10-03
First posted
2017-09-01
Last updated
2023-04-12

Locations

1 site across 1 country: Bulgaria

Source: ClinicalTrials.gov record NCT03270150. Inclusion in this directory is not an endorsement.

Effect of the BTL-899 Therapy for Non-invasive Lipolysis and Circumference Reduction of Abdomen (NCT03270150) · Clinical Trials Directory